NAION / Eye Stroke

NAION is an eye stroke of the optic nerve — blood flow to the front of the optic nerve is cut off, damaging the fibers that carry visual signals to the brain. A retinal occlusion is an eye stroke of the retina — a blocked artery or vein stops circulation to the light-sensing tissue itself. Both cause sudden vision loss and share the same vascular risk factors.

Partial recovery is possible — especially when care begins within weeks. Dr. Rosenfarb often sees field gains after a series of acupuncture, laser, and ACS-3000 sessions.

Treat NAION or eye stroke like any stroke: the sooner circulation and inflammation are addressed, the more cells can be saved. Aim for treatment within the first 4–6 weeks.

Most people never get a second episode, but shared risk factors (sleep apnea, hypertension, diabetes) can endanger the fellow eye. Managing those risks and supporting nerve health lowers the odds.

Yes, but it usually appears in one eye first. Having an occlusion raises the risk of it happening in the fellow eye, so monitoring is crucial.

Mild, non-ischemic cases may regain most visual acuity, especially if treated promptly. Severe ischemic occlusions often leave permanent deficits, though treatment can maximize remaining vision.

They may reduce swelling or bleeding but don't regenerate nerve tissue. Pairing conventional drugs with oxygenation and neuro-stimulation offers a more complete strategy.

EHI prioritizes CBD-rich Catavision for inflammation, Total MA-48 for micro-circulation, neuronal support formulas, high-dose DHA, taurine, and molecular hydrogen for oxidative stress control.

Ideally within hours. Although some therapies can still help days later, early diagnosis and prompt treatment offer the best chance to preserve or restore vision.